US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

AKTX

Akari Therapeutics (AKTX)

Akari Therapeutics PLC

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AKTX

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/05/2024	16:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AKTX	Akari Therapeutics PLC
15/03/2024	11:53	PR Newswire (US)	Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm	NASDAQ:AKTX	Akari Therapeutics PLC
11/03/2024	16:25	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:AKTX	Akari Therapeutics PLC
09/01/2024	16:25	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:AKTX	Akari Therapeutics PLC
04/01/2024	11:34	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:AKTX	Akari Therapeutics PLC
02/01/2024	19:06	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AKTX	Akari Therapeutics PLC
01/12/2023	07:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AKTX	Akari Therapeutics PLC
27/10/2023	15:15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:AKTX	Akari Therapeutics PLC
26/10/2023	23:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:AKTX	Akari Therapeutics PLC
20/10/2023	15:29	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:AKTX	Akari Therapeutics PLC
20/10/2023	15:23	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:AKTX	Akari Therapeutics PLC
12/10/2023	15:43	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:AKTX	Akari Therapeutics PLC
07/06/2023	05:03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AKTX	Akari Therapeutics PLC
06/06/2023	08:00	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AKTX	Akari Therapeutics PLC
31/05/2023	16:08	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AKTX	Akari Therapeutics PLC
16/05/2023	15:05	GlobeNewswire Inc.	Aspira Women’s Health Names Torsten Hombeck as Chief Financial Officer	NASDAQ:AKTX	Akari Therapeutics PLC
14/04/2023	15:07	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AKTX	Akari Therapeutics PLC
14/02/2023	15:14	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AKTX	Akari Therapeutics PLC
09/11/2022	15:13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:AKTX	Akari Therapeutics PLC
04/11/2022	16:01	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1/a)	NASDAQ:AKTX	Akari Therapeutics PLC
12/10/2022	15:32	Edgar (US Regulatory)	Securities Registration (foreign Private Issuer) (f-1)	NASDAQ:AKTX	Akari Therapeutics PLC
14/09/2022	11:20	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:AKTX	Akari Therapeutics PLC
13/06/2022	06:00	GlobeNewswire Inc.	Akari Therapeutics Announces the Appointment of Accomplished Biotech Executive Melissa Bradford-Klug as Chief Operating Officer to Lead Business Development and Company Growth Strategies	NASDAQ:AKTX	Akari Therapeutics PLC
19/05/2022	15:05	GlobeNewswire Inc.	Akari Therapeutics Presents Results from the CASCADE and CORONET Studies in COVID-19 at the American Thoracic Society (ATS) 2022 Annual Meeting	NASDAQ:AKTX	Akari Therapeutics PLC
16/05/2022	05:43	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:AKTX	Akari Therapeutics PLC
16/05/2022	05:00	GlobeNewswire Inc.	Akari Therapeutics Reports Full Year 2021 Financial Results and Highlights Clinical Progress	NASDAQ:AKTX	Akari Therapeutics PLC
11/05/2022	06:00	GlobeNewswire Inc.	Akari Therapeutics to Present Results from Compassionate Use of Nomacopan for COVID-19 (CORONET) and Identification of Clinical Deterioration Risk in COVID-19 (CASCADE) at the American Thoracic Society (ATS) 2022 Annual Meeting	NASDAQ:AKTX	Akari Therapeutics PLC
10/05/2022	06:00	GlobeNewswire Inc.	Akari Therapeutics Announces Publication of Phase II Data of Investigational Nomacopan for the Treatment of Bullous Pemphigoid (BP) in JAMA Dermatology	NASDAQ:AKTX	Akari Therapeutics PLC
09/05/2022	06:00	GlobeNewswire Inc.	Akari Presents Results from Two Preclinical Development Programs of Long-Acting PAS-Nomacopan in Geographic Atrophy (GA) Dry Age-Related Macular Degeneration and Nomacopan in Experimental Immune-Mediated Conjunctival Disease (EIC)	NASDAQ:AKTX	Akari Therapeutics PLC
29/04/2022	16:11	Edgar (US Regulatory)	Notification That Form 20-f Will Be Submitted Late (nt 20-f)	NASDAQ:AKTX	Akari Therapeutics PLC

Showing the most relevant articles for your search:NASDAQ:AKTX

1 2 3 4 5 6 7 Próxima >

JP Morgan Chase

American Express

Verizon Communications

Deutsche Telekom (QX)

Financial Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones